A recent survey showed moderate to high adherence for antifungal therapeutic drug monitoring adherence, though there was room for improvement, specifically when using certain antifungals as prophylaxis.
“We recently conducted an analysis looking at the utilization of antifungal therapeutic drug monitoring (TDM) among people in hospitals receiving itraconazole, posaconazole, and voriconazole. TDM is testing that checks the amount of a drug that is in a patient’s blood,” Dallas J. Smith, PharmD, epidemiologist in CDC’s Mycotic Diseases Branch, told Healio. “We found